纳米粒子介导的向蛋白质降解:一种新兴的治疗技术
Andrew G Baker1,2, Adrian Pui Ting Ho1,2, Laura S Itzhaki1
1Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge, CB2 1PD, UK.
Angewandte Chemie (International ed. in English)
|May 5, 2025
概括
向蛋白质降解 (TPD) 使用纳米粒子清除疾病蛋白质. 纳米颗粒介导蛋白质降解剂 (NanoPDs) 提供了新的治疗途径,但在临床转化方面面临挑战.
科学领域:
- 生物技术是生物技术.
- 药物发现 药物发现 药物发现
- 纳米医学是一种纳米医学.
背景情况:
- 向蛋白质降解 (TPD) 是各种疾病的有前途的治疗策略.
- 小分子降解剂面临的挑战包括溶解性差和细胞吸收.
- 纳米颗粒介导蛋白质降解剂 (NanoPDs) 为TPD提供了一种替代方法.
研究的目的:
- 提供纳米粒子介导TPD的全面概述.
- 讨论TPD中纳米-生物接口的设计原则.
- 探索近距离诱导的生物学在编排蛋白质相互作用.
主要方法:
- 对TPD和NanoPDs现有文献的审查.
- 对纳米粒子介导降解的设计原则的分析.
- 探索生物机制,包括近距离诱导生物学.
主要成果:
- 纳米PDs利用不同的材料和机制来清除蛋白质.
- 设计原则侧重于纳米-生物接口和近距离诱导生物学.
- 挑战包括溶解体捕获,蛋白质冠状和生物相容性.
结论:
- 纳米PDs为治疗性蛋白质降解提供了一个新的平台.
- 解决纳米生物相互作用和生物相容性方面的挑战对于临床转化至关重要.
- 需要进一步的研究来释放纳米PDs的全部治疗潜力.
更多相关视频
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
16.6K
09:51Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
Published on: July 26, 2017
12.3K
相关概念视频
Regulated Protein Degradation
2.4K
2.4K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
The Proteasome
779
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
779
Protein Networks
3.9K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K
